Menopause Hormone Therapy (HRT) in West Palm Beach, FL

Bioidentical hormones in West Palm Beach: what it means

"Bioidentical" describes a hormone whose chemical structure matches one the body makes. Estradiol and micronized progesterone are both bioidentical: their structure matches the hormones the ovaries make. FDA-approved versions of both are sold by prescription at retail pharmacies.

"BHRT" often means compounded hormones, a cream, a blend such as Bi-Est or a pellet that a pharmacy mixes for one prescription. They are not FDA-approved, which means the FDA cannot assure their safety or effectiveness. The FDA also says it has no evidence that they are safe and effective, or more effective than approved hormone therapy. A 2020 National Academies review found no rigorous evidence of their safety and effectiveness.

For women in West Palm Beach, a physician licensed in Florida can prescribe estradiol (pill, patch, cream or vaginal) and progesterone when they fit your history. There are no pellets. Because the dispensing pharmacy also compounds, you can ask whether your estradiol or progesterone is an FDA-approved product. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

The NPI registry counts 56 OB-GYNs practicing in West Palm Beach, about 46.9 for every 100,000 residents against 17.8 nationally and above Florida's 16.5, a higher rate than 84% of the cities VevaMD covers. That is about 270 women aged 45 to 64 for each OB-GYN in the city, a ratio rather than a count of open appointments.

Widen the circle and the count grows: 85 in the city or within 10 miles, 211 within 25 miles. For the 1,365,030 people who live within 25 miles, that is 15.5 per 100,000. Whether or not you have an OB-GYN, you can ask a physician licensed in Florida about menopause hormone therapy online from West Palm Beach, with no waiting room.

Then there are pellets, implanted under the skin at a clinic; compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG advises FDA-approved hormone therapy over compounded preparations.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11